MyMD Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Share-based Payments (Tables)

Share-based Payments (Tables)

12 Months Ended

Dec. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation Warrants Activity

The following table summarizes the warrant activities for the years ended December 31, 2015 and 2014:

				Weighted
	Number of			Average
	Shares			Exercise Price
*Balance at December 31, 2014 and 2013*		1,989		$	71.76
Granted		-			-
Exercised		-			-
Forfeited		-			-
Canceled/Expired		(1,989	)		71.76
*Balance at December 31, 2015*		-		$	-

Schedule of operations and comprehensive loss

The calculated fair value of these options was distributed to the following categories on the consolidated statement of operations and comprehensive loss:

Expense Category	2015		2014
Cost of Goods	$	5,909	$	24,040
General & Administrative		-		357,276
Sales & Marketing		1,617		48,081
Research & Development		44,830		120,203
	$	52,356	$	549,600

Schedule of Options And Warrants Valuation Assumptions Under Black Scholes Pricing Model

The options and warrants issued under the above plan were valued using a Black Scholes option pricing model. The assumptions utilized in calculating the value of the issued options under Black Scholes are as follows:

	2015			2014
Expected option term		5 yrs			5 yrs
Expected volatility		82.86	%		127.32	%
Expected dividend yield		0.00	%		0.00	%
Risk free interest rate		1.73	%		1.71	%

Summary of Stock Options Activity

The following table summarizes the option activities for the years ended December 31, 2015 and 2014:

					Weighted
			Weighted		Average
			Average		Remaining		Aggregate
	Number of		Exercise		Contractual		Intrinsic
	Shares		Price		Term (years)		Value
*Balance at December 31, 2013*		-	$	-
Granted		175,000		4.98
Exercised		-		-
Forfeited		-		-
Canceled/Expired		-		-
*Balance at December 31, 2014*		175,000	$	4.98
*Exercisable as of December 31, 2014*		175,000	$	4.98		4.50	$	600

*Balance at December 31, 2014*		175,000	$	4.98
Granted		45,500		2.07
Exercised		-		-
Forfeited		-		-
Canceled/Expired		-		-
*Balance at December 31, 2015*		220,500	$	4.38
*Exercisable as of December 31, 2015*		220,500	$	4.38		3.81	$	-

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details